Community Practice

Pharmacists push innovative medication therapy management models.

Pharmacists are up in arms over the warning FDA has issued to seven compounding pharmacies about bioidentical hormone replacement therapy.

Pharmacists speak out about a behind-the-counter class of drugs, pharmacy coupons, and Mevacor going OTC.

Industry supports FDAs decision against OTC cough and cold medicines for children under two

Sandoz's Omnitrope Pen 5 has been cleared for treating kids with growth failure and adults with growth hormone deficiency on a long-term basis

Colesevelam approved for new indication

Patients asking pharmacists about Vytorin controversy

The proposed First DataBank settlement that would have discontinued AWP has been denied by a federal court judge.

The Clinic at Wal-Mart to open in Atlanta, Little Rock, and Dallas.

The National Council for Prescription Drug Programs is exploring the issue of what standards should be established for electronic medication administration records in long-term care.

Merck's $650 million settlement for two Medicaid fraud suits is expected to yield a windfall for participants in the 340B drug discount program.

The American Society of Addiction Medicine urges physicians to prescribe opioids with care following the death of actor Heath Ledger.

New Mexico to vote on dispensing fee bill.

Here are more new otcs that treat everything from aches and pains to chapped lips.

New studies support the use of fixed dose antihypertensive combination therapy at the outset of hypertension treatment.

All prescription drugs should have a sell-by date for consistency and patient protection.

New brand drugs, generics, and over-the-couter products.

New federal leglsation would mandate electronic prescriptions, dividing healthcare providers even the practice gains more acceptance.

Pharmacists have temporarily blocked the Medicaid AMP formula, but a bruising battle still awaits.

Pharmacists must observe HIPAA regulations and also have a clear duty to warn patients.

FDA approves a new molecular entity, Kuvan, to treat phenylketonuria.

Pharmacists speak out about a behind-the-counter class of drugs, pharmacy coupons, and Mevacor going OTC.

Here are the winners of the Drug Topics' 150th Anniversary history contest

In a speech to its employees, Wal-Mart CEO signals the company's intention to get into the pharmacy benefit management business

The Centers for Medicare & Medicaid Services is seeking comment on the draft of its 2009 call letter for prescription drug plans.

New York governor proposes bulk prescription drug purchasing and a discount Rx Card in a new budget proposal.

First generic alendronate sodium tablets approved

Injectable colchicine is removed from the market by FDA

CVS Samaritan Van program celebrates 30 years of helping motorists

VTE under treated according to ENDORSE